Learn more about uBriGene's CAR-T CDMO manufacturing for high-quality therapies.
Download Brochure
Explore the fundamentals of RNA drug development and the critical role of in vitro transcription (IVT) in manufacturing workflows.
Learn how uBriGene can be your bridge from ATMPs concept to commercialization.
Explore uBriGene’s robust GMP plasmid manufacturing process and testing capabilities.
Power of IVT-produced highly stable mRNA + microflu-idics LNP encapsulation
uBriGene's LVV manufacturing platform accelerates time to clinic with ready-to-use cell lines and LVV helper plasmids for high-quality, large-scale vector production.
uBriGene's iPSC CDMO platforms deliver GMP-compliant cell therapy development with advanced production, strict quality testing, and full IND support.
uBriGene provides comprehensive CRO services for CGT, including tech transfer, process development, and scale-up, helping clients reduce timelines and costs.
Learn more about uBriGene's CAR-T CDMO manufacturing for high-quality therapies.
uBriGene's AAV manufacturing platform speeds time to clinic with off-the-shelf cell lines and AAV helper plasmids, enabling high-quality vector production up to 2000L scale.
